Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

The new drug sotatercept stops the remodelling of the pulmonary vessels and even helps patients with advanced pulmonary arterial hypertension (PAH) who have not yet been treated.

In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...

Not everybody with blockages needs surgical intervention. Guidelines recommend against surgery in people with no symptoms and ...

A recent publication by the British Thoracic Society offers the first long-term analysis of the UK Idiopathic Pulmonary ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive ...

"While our findings suggest a substantial role for PADN in treatment protocols ... for patients with complex conditions like pulmonary hypertension. More information: Mohamed Riad Abouzid et ...

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

Researchers from China Pharmaceutical University and Jiangsu Nhwa Pharmaceutical Co. Ltd. have synthesized azetidine-containing compounds acting as muscarinic M4 receptor positive allosteric ...